Biosimilar Testing and Development Services Market to Hold $7.8 Billion, by 2032 with 12.1% CAGR: Allied Market Research [Yahoo! Finance]
Charles River Laboratories International, Inc. (CRL)
Last charles river laboratories international, inc. earnings: 2/11 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.criver.com
Company Research
Source: Yahoo! Finance
testing, patent expiration of original drugs, and rise in demand for biosimilar products PORTLAND, Ore. April 29, 2024 /PRNewswire/ -- Allied Market Research published a report titled, " Biosimilar Testing and Development Services Market Share, Size, Competitive Landscape and Trend Analysis Report by Type, by End User: Global Opportunity Analysis and Industry Forecast, 2023-2032." The report states that the global biosimilar testing and development services sector is expected to generate $7.8 billion with a notable CAGR of 12.1% during the forecast period of 2023 to 2032. The sector garnered $2.5 billion in 2022. The report offers a detailed analysis of top segments, dynamic market trends, value chain, pricing, key investment areas, competitive scenario, and regional landscape. Request Sample of the Report on Biosimilar Testing and Development Services Market Forecast - https://www.alliedmarketresearch.com/request-sample/3972 Report Coverage Details Forecast Period 2022–20
Show less
Read more
Impact Snapshot
Event Time:
CRL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRL alerts
High impacting Charles River Laboratories International, Inc. news events
Weekly update
A roundup of the hottest topics
CRL
News
- Don't Overlook Charles River (CRL) International Revenue Trends While Assessing the Stock [Yahoo! Finance]Yahoo! Finance
- Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at TD Cowen from $260.00 to $228.00. They now have a "hold" rating on the stock.MarketBeat
- Why Charles River Laboratories (CRL) is a Top Value Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
- Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at Robert W. Baird from $282.00 to $270.00. They now have an "outperform" rating on the stock.MarketBeat
CRL
Earnings
- 5/9/24 - Beat
CRL
Sec Filings
- 5/15/24 - Form 4
- 5/15/24 - Form 144
- 5/14/24 - Form 4
- CRL's page on the SEC website